Ca2+ but not H2O2 modulates GRE-element activation by the human mineralocorticoid receptor in HEK cells

Molecular and Cellular Endocrinology

Volumn 264, Issue 1-2, 2007, Pages 35-43

  Pfau, Anja ^a   Grossmann, Claudia ^a   Freudinger, Ruth ^a   Mildenberger, Sigrid ^a   Benesic, Andreas ^a   Gekle, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aldosterone; Calcium; H2O2; MAP kinase; Mineralocorticoid receptor; Protein kinase A; Protein kinase C

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ALDOSTERONE; CALCIUM; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOCORTICOID RECEPTOR; HYDROGEN PEROXIDE; IONOMYCIN; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; THAPSIGARGIN; WATER; CHELATING AGENT; ENZYME INHIBITOR; IONOPHORE; OXIDIZING AGENT; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN HEK293; CHELATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE CONSTRUCT; GENETIC TRANSFECTION; HEART MUSCLE FIBROSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSACTIVATION; BIOSYNTHESIS; CALCIUM SIGNALING; CELL LINE; CYTOLOGY; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG EFFECT; EMBRYO; KIDNEY; METABOLISM; PHYSIOLOGY;

CALCIUM; CALCIUM SIGNALING; CELL LINE; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; IONOMYCIN; IONOPHORES; KIDNEY; OXIDANTS; PROTEIN KINASES; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RESPONSE ELEMENTS;

EID: 33846225245     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.10.002     Document Type: Article

References (35)

1. Agarwal A.K., and Auchus R.J. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 146 (2005) 2531-2538
2. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., and Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 (1987) 268-275
3. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77 (1993) 817-827
4. Blasi E.R., Rocha R., Rudolph A.E., Blomme E.A., Polly M.L., and McMahon E.G. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 63 (2003) 1791-1800
5. Feng W., Webb P., Nguyen P., Liu X., Li J., Karin M., and Kushner P.J. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol. Endocrinol. 15 (2001) 32-45
6. 2+ and stimulation of a plasma membrane proton conductance. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10500-10504
7. Gekle M., Freudinger R., Mildenberger S., and Silbernagl S. Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. Am. J. Physiol. Renal Physiol. 282 (2002) F669-F679
8. Govindan M.V., and Warriar N. Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. J. Biol. Chem. 273 (1999) 24439-24447
9. + reabsorption. Am. J. Physiol. Renal. Physiol. 286 (2004) F1226-F1231
10. Grossmann C., Scholz T., Rochel M., Bumke-Vogt C., Oelkers W., Pfeiffer A.F., Diederich S., and Bahr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur. J. Endocrinol. 151 (2004) 397-406
11. Grossmann C., Benesic A., Krug A.W., Freudinger R., Mildenberger S., Gassner B., and Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endocrinol. 19 (2005) 1697-1710
12. Hecquet C., Tan F., Marcic B.M., and Erdos E.G. Human bradykinin B2 receptor is activated by kallikrein and other serine proteases. Mol. Pharmacol. 58 (2000) 828-836
13. Iida T., Makino Y., Okamoto K., Yoshikawa N., Makino I., Nakamura T., and Tanaka H. Functional modulation of the mineralocorticoid receptor by cis-diamminedichloroplatinum (II) 58 (2000) 1450-1460
14. Krug A.W., Grossmann C., Schuster C., Freudinger R., Mildenberger S., Govindan M.V., and Gekle M. Aldosterone stimulates epidermal growth factor receptor (EGFR) expression. J. Biol. Chem. 278 (2003) 43060-43066
15. Lacy F., Kailasam M.T., O'Connor D.T., Schmid-Schonbein G.W., and Parmer R.J. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36 (2000) 878-884
16. Le Moellic C., Ouvrard-Pascaud A., Capurro C., Cluzeaud F., Fay M., Jaisser F., Farman N., and Blot-Chabaud M. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response. J. Am. Soc. Nephrol. 15 (2004) 1145-1160
17. Lim-Tio S.S., and Fuller P.J. Intracellular signaling pathways confer specificity of transactivation by mineralocorticoid and glucocorticoid receptors. Endocrinology 139 (1998) 1653-1661
18. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 4 (2003) 46-56
19. Mansouri A., Muller F.L., Liu Y., et al. Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech. Ageing Dev. 127 (2006) 298-306
20. Massaad C., Houard N., Lombes M., and Barouki R. Modulation of human mineralocorticoid receptor function by protein kinase A. Mol. Endocrinol. 13 (1999) 57-65
21. Mazak I., Fiebeler A., Muller D.N., et al. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 109 (2004) 2792-2800
22. Odermatt A., Arnold P., and Frey F.J. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J. Biol. Chem. 276 (2001) 28484-28492
23. Ouvrard-Pascaud A., Puttini S., Sainte-Marie Y., et al. Conditional gene expression in renal collecting duct epithelial cells: use of the inducible Cre-lox system. Am. J. Physiol. Renal Physiol. 286 (2004) F180-F187
24. Pascual-Le Tallec L., and Lombes M. The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Mol. Endocrinol. 19 (2005) 2211-2221
25. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J., and Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341 (1999) 709-717
26. Piwien-Pilipuk G., Ayala A., Machado A., and Galigniana M.D. Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging. Correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongation factor 2 in kidney cells. J. Biol. Chem. 277 (2002) 11896-11903
27. Rochette-Egly C. Dynamic combinatorial networks in nuclear receptor-mediated transcription. J. Biol. Chem. 280 (2005) 32565-32568
28. Rogatsky I., Waase C.L., and GARABEDIAN M.J. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revlealed through GSK-3 phosphorylation. J. Biol. Chem. 273 (1998) 14315-14321
29. Rogerson F.M., Dimopoulos N., Sluka P., Chu S., Curtis A.J., and Fuller P.J. Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J. Biol. Chem. 274 (1999) 36305-36311
30. Rogerson F.M., Brennan F.E., and Fuller P.J. Mineralocorticoid receptor binding, structure and function. Mol. Cell Endocrinol. 217 (2004) 203-212
31. Rossier B.C., Pradervand S., Schild L., and Hummler E. Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu. Rev. Physiol. 64 (2002) 877-897
32. Rupprecht R., Arriza J.L., Spengler D., Reul J.M., Evans R.M., Holsboer F., and Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol. Endocrinol. 7 (1993) 597-603
33. Vasudevan N., Kow L.M., and Pfaff D.W. Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12267-12271
34. Versteeg H.H., Nijhuis E., Van den Brink G.R., Evertzen M., Pynaert G.N., van Deventer S.J., Coffer P.J., and Peppelenbosch M.P. A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem. J. 350 Pt 3 (2000) 717-722
35. Wohlfarth V., Drumm K., Mildenberger S., Freudinger R., and Gekle M. Protein uptake disturbs collagen homeostasis in proximal tubule-derived cells. Kidney Int. Suppl. 84 (2003) 103-109